Cardlytics Other Liab from 2010 to 2024

CDLX Stock  USD 3.93  0.12  2.96%   
Cardlytics Other Liabilities yearly trend continues to be fairly stable with very little volatility. Other Liabilities will likely drop to about 364.9 K in 2024. During the period from 2010 to 2024, Cardlytics Other Liabilities regression line of annual values had r-squared of  0.02 and arithmetic mean of  6,908,733. View All Fundamentals
 
Other Liabilities  
First Reported
2015-12-31
Previous Quarter
58 K
Current Value
334 K
Quarterly Volatility
22.8 M
 
Yuan Drop
 
Covid
Check Cardlytics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cardlytics' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 3.4 M or Depreciation And Amortization of 16.7 M, as well as many indicators such as Price To Sales Ratio of 1.03, Dividend Yield of 0.0 or PTB Ratio of 3.76. Cardlytics financial statements analysis is a perfect complement when working with Cardlytics Valuation or Volatility modules.
  
Check out the analysis of Cardlytics Correlation against competitors.
For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.

Latest Cardlytics' Other Liab Growth Pattern

Below is the plot of the Other Liab of Cardlytics over the last few years. It is Cardlytics' Other Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cardlytics' overall financial position and show how it may be relating to other accounts over time.
Other Liab10 Years Trend
Pretty Stable
   Other Liab   
       Timeline  

Cardlytics Other Liab Regression Statistics

Arithmetic Mean6,908,733
Geometric Mean2,770,904
Coefficient Of Variation194.97
Mean Deviation6,979,405
Median4,305,000
Standard Deviation13,469,684
Sample Variance181.4T
Range54.2M
R-Value0.14
Mean Square Error191.8T
R-Squared0.02
Significance0.63
Slope410,317
Total Sum of Squares2540.1T

Cardlytics Other Liab History

2024364.9 K
2023384.1 K
2022334 K
202154.5 M
2020679 K
20192.6 M
20183.2 M

About Cardlytics Financial Statements

Cardlytics investors use historical fundamental indicators, such as Cardlytics' Other Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Cardlytics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Liabilities384.1 K364.9 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Cardlytics Stock Analysis

When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.